These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26458950)

  • 1. Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin.
    Palladino G; Loizzo S; Fortuna A; Canterini S; Palombi F; Erickson RP; Mangia F; Fiorenza MT
    Orphanet J Rare Dis; 2015 Oct; 10():133. PubMed ID: 26458950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
    Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
    Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.
    Muralidhar A; Borbon IA; Esharif DM; Ke W; Manacheril R; Daines M; Erickson RP
    Mol Genet Metab; 2011 Jun; 103(2):142-7. PubMed ID: 21459030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.
    Holzmann C; Witt M; Rolfs A; Antipova V; Wree A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
    Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
    PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
    Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
    Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
    Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity.
    Zhou Y; Takahashi S; Homma K; Duan C; Zheng J; Cheatham MA; Zheng J
    Acta Neuropathol Commun; 2018 Sep; 6(1):98. PubMed ID: 30249300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ Weights in
    Antipova V; Steinhoff LM; Holzmann C; Rolfs A; Hempel CJ; Witt M; Wree A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.
    Peake KB; Vance JE
    J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.
    Cougnoux A; Clifford S; Salman A; Ng SL; Bertin J; Porter FD
    Mol Genet Metab; 2018 Dec; 125(4):345-350. PubMed ID: 30392741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.
    Meyer A; Wree A; Günther R; Holzmann C; Schmitt O; Rolfs A; Witt M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
    Ory DS; Ottinger EA; Farhat NY; King KA; Jiang X; Weissfeld L; Berry-Kravis E; Davidson CD; Bianconi S; Keener LA; Rao R; Soldatos A; Sidhu R; Walters KA; Xu X; Thurm A; Solomon B; Pavan WJ; Machielse BN; Kao M; Silber SA; McKew JC; Brewer CC; Vite CH; Walkley SU; Austin CP; Porter FD
    Lancet; 2017 Oct; 390(10104):1758-1768. PubMed ID: 28803710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
    Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
    Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling.
    Fan M; Sidhu R; Fujiwara H; Tortelli B; Zhang J; Davidson C; Walkley SU; Bagel JH; Vite C; Yanjanin NM; Porter FD; Schaffer JE; Ory DS
    J Lipid Res; 2013 Oct; 54(10):2800-14. PubMed ID: 23881911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased neural stem cell proliferation and olfaction in mouse models of Niemann-Pick C1 disease and the response to hydroxypropyl-β-cyclodextrin.
    Dragotto J; Palladino G; Canterini S; Caporali P; Patil R; Fiorenza MT; Erickson RP
    J Appl Genet; 2019 Nov; 60(3-4):357-365. PubMed ID: 31485950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.
    Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU
    PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).
    Tortelli B; Fujiwara H; Bagel JH; Zhang J; Sidhu R; Jiang X; Yanjanin NM; Shankar RK; Carillo-Carasco N; Heiss J; Ottinger E; Porter FD; Schaffer JE; Vite CH; Ory DS
    Hum Mol Genet; 2014 Nov; 23(22):6022-33. PubMed ID: 24964810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
    Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.
    Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
    Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.